Table 2.
Causes of death in patients randomised to treatment with endovascular strategy (endovascular repair if aortic morphology is suitable, open repair if not) or open repair by group by time period for all randomised patients (n=613)
| Endovascular strategy (n=316) | Open repair (n=297) | Unadjusted hazard ratio (95% CI) | P value | |
|---|---|---|---|---|
| All follow-up | ||||
| Related to the aneurysm | 112 | 120 | 0.92 (0.75 to 1.13) | 0.41 |
| Cardiovascular | 26 | 23 | ||
| Pulmonary | 13 | 15 | ||
| Cancer | 19 | 13 | ||
| Other | 9 | 12 | ||
| Total | 179 | 183 | ||
| 0-3 months | ||||
| Related to the aneurysm | 104 | 112 | 0.98 (0.76 to 1.26) | 0.88 |
| Cardiovascular | 8 | 3 | ||
| Pulmonary | 5 | 0 | ||
| Cancer | 1 | 0 | ||
| Other | 2 | 3 | ||
| Total | 120 | 118 | ||
| 3 months-3 years | ||||
| Related to the aneurysm | 5 | 5 | 0.57 (0.36 to 0.90) | 0.015 |
| Cardiovascular | 12 | 16 | ||
| Pulmonary | 5 | 10 | ||
| Cancer | 7 | 10 | ||
| Other | 2 | 6 | ||
| Total | 31 | 47 | ||
| >3 years | ||||
| Related to the aneurysm | 3 | 3 | 1.44 (0.80 to 2.62) | 0.23 |
| Cardiovascular | 6 | 4 | ||
| Pulmonary | 3 | 5 | ||
| Cancer | 11 | 3 | ||
| Other | 5 | 3 | ||
| Total | 28 | 18 | ||